Cresset Announces Excellent 2012 Sales Figures and Growth
News Jan 22, 2013
Dr Robert Scoffin, CEO of Cresset, says, “We are delighted to announce robust growth through 2012 in both our software and services divisions. We have invested in the rebranding of our software tools and now have an even more professional software workbench for medicinal and computational chemists. This is complemented by our growing Consulting Services division, including the first full year of operation of our innovative CompChem-on-Demand service.”
“The breadth and range of consulting projects that Cresset undertakes demonstrates the power and scope of Cresset’s underlying patented technology,” says Dr Martin Slater, Head of Consulting. “We have completed consulting projects this year on research areas as diverse as virtual screening against a novel rheumatoid arthritis target and discovery of new sweeteners for a global drinks manufacturer.”
Dr Scoffin adds, “As companies increasingly choose to outsource computational chemistry in order to take advantage of just-in-time expertise, we expect Cresset to continue to enjoy outstanding growth throughout and beyond 2013.”
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.